Determine what vaccination programme should be followed for preterm babies to help protect them against meningococcal disease
Professor Paul Heath, Dr Anna Calvert, Dr Shamez Ladhani, Dr Helen Findlow examine babies born Early Antibody Response to MenB vaccination.
Dr Marie Yang, Dr Stavros Panagiotou and Prof Aras Kadioglu continue their research into pneumococcal meningitis.
Dr Rachel Exley and Prof Christoph Tang research Understanding the biology of Neisseria cinerea for the prevention of meningococcal disease.
Professor Jeremy Brown at University College London is researching ways to make a cheaper, more effective vaccine to protect against pneumococcal meningitis.
Professors Paul Langford and Simon Kroll are investigating the impact of MenB vaccination on bacterial carriage in babies and young children.
Professor John Heckels at the University of Southampton is researching ways to make new, more effective vaccines against meningococcal group B and other strains of meningococcal disease.
Defining the role of gut bacteria in the development of septicaemia and meningitis in premature babies - London
Professor Simon Kroll at Imperial College London has investigated the complex populations of bacteria found in the gut of premature babies who develop septicaemia and meningitis.
Professor Christoph Tang, Professor Susan Lea, Professor Matthew Pickering, Professor Ray Borrow, Dr Ilse Jongerius researched the development of a broadly protective vaccine against meningococcal disease .
Professor Jon Sayers, Professor Andrew Heath, Professor Robert Read's research examined offering better protection against meningococcal disease.
Professors Robert Read and Andrew Gorringe at the University of Sheffield looked for new ways to stop people carrying the bacteria which causes meningococcal disease.
Dr Shamez Ladhani at Public Health England's research project Estimating the total burden of invasive meningococcal disease in England using multiple data sources
Dr Dean Everett, Prof Aras Kadioglu and Dr Marie Yang are researching the fast track development of novel therapeutics and vaccine candidates against pneumococcal meningitis
Professor Heath is researching the current disease burden of Group B streptococcus (GBS) disease in the UK and attitudes of pregnant women towards GBS vaccination.
Professor Andrew Heath at the University of Sheffield will be using a new approach to vaccine design that could lead to complete protection against meningococcal group B disease.
Dr Jay Lucidarme at Public Health England is investigating whether genetics can help us understand how the meningococcal germ causes disease.
Professor Paul Langford at Imperial College London is working to improve protection against meningococcal group B, by identifying new ways to build vaccines.
Meningococcal bacteria are a common cause of meningitis and septicaemia. Professor Mumtaz Virji and Dr Darryl Hill at the University of Bristol are working towards a vaccine to prevent all meningococcal disease.
Evaluating how to reduce the risk of contracting meningococcal disease in patients with low immunity - Manchester
Dr Stephen Hughes at Central Manchester University Hospitals NHS Foundation Trust will examine how to protect people with low immunity from contracting meningococcal disease.